Science and Research

Brigatinib-5007

A Cohort Study to Describe the Occurrence of Early-Onset Pulmonary Events in
Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer
Treated with Brigatinib: A Post-Authorisation Safety Study

Study details
DZL Disease Area: LC
DZL Disease Area: LC
Study Type: Observational
Study Type: Observational
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: BIH / Charité - Associated Partner
DZL Participating Sites: BIH / Charité - Associated Partner
Start Date: 10.12.2020
Completion Date: 31.12.2024
Status: Closed
Status: Closed
DZL recruiting center


chevron-down